鹿得医疗
(920278)
| 流通市值：7.29亿 | | | 总市值：17.19亿 |
| 流通股本：7404.80万 | | | 总股本：1.75亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 216,474,324.02 | 133,362,208.22 | 61,093,741.9 | 344,603,098.61 |
| 营业收入 | 216,474,324.02 | 133,362,208.22 | 61,093,741.9 | 344,603,098.61 |
| 二、营业总成本 | 201,297,903.75 | 125,670,952 | 57,011,725.38 | 313,957,259.77 |
| 营业成本 | 160,188,545.28 | 99,280,167.97 | 44,536,747.54 | 257,427,204.61 |
| 税金及附加 | 2,079,485.79 | 1,671,558.88 | 1,136,026.09 | 2,973,369.72 |
| 销售费用 | 17,490,308.3 | 11,166,435.57 | 5,041,404.77 | 21,886,438.82 |
| 管理费用 | 15,226,796.37 | 10,084,909.93 | 4,450,250.99 | 22,293,272.6 |
| 研发费用 | 9,526,381.69 | 6,340,283.2 | 2,960,136.9 | 14,994,455.1 |
| 财务费用 | -3,213,613.68 | -2,872,403.55 | -1,112,840.91 | -5,617,481.08 |
| 其中:利息费用 | 867,247.36 | 563,142.1 | 253,314.2 | 389,316.18 |
| 其中:利息收入 | 2,415,949.81 | 1,591,417.76 | 679,517.88 | 2,733,943.52 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,066,891.9 | 603,334.93 | -61,705.27 | 110,451.54 |
| 加:投资收益 | 500,503.03 | -99,393.91 | -41,208.75 | 1,604,777.73 |
| 资产处置收益 | - | - | - | 13,125.32 |
| 资产减值损失(新) | 46,900.05 | 172,343.83 | 6,961.39 | -348,365.89 |
| 信用减值损失(新) | 1,932,697.08 | 2,232,669.52 | 2,877,616.57 | -2,729,005.1 |
| 其他收益 | 870,116.32 | 476,819.59 | 155,103.44 | 1,081,151.16 |
| 四、营业利润 | 19,593,528.65 | 11,077,030.18 | 7,018,783.9 | 30,377,973.6 |
| 加:营业外收入 | 46,863.69 | 46,382.66 | 25.38 | 5,494.75 |
| 减:营业外支出 | 274,194.83 | 269,369.05 | 1,605.89 | 171,198.83 |
| 五、利润总额 | 19,366,197.51 | 10,854,043.79 | 7,017,203.39 | 30,212,269.52 |
| 减:所得税费用 | 1,859,947.43 | 1,036,463.8 | 739,293.32 | 2,722,083.49 |
| 六、净利润 | 17,506,250.08 | 9,817,579.99 | 6,277,910.07 | 27,490,186.03 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 17,506,250.08 | 9,817,579.99 | 6,277,910.07 | 27,490,186.03 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 17,686,935 | 9,932,883.2 | 6,334,320.18 | 27,544,279.22 |
| 少数股东损益 | -180,684.92 | -115,303.21 | -56,410.11 | -54,093.19 |
| 扣除非经常损益后的净利润 | 16,242,048.25 | 9,217,787.71 | 6,253,230.2 | 26,207,980.39 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.1 | 0.06 | 0.04 | 0.16 |
| (二)稀释每股收益 | 0.1 | 0.06 | 0.04 | 0.16 |
| 八、其他综合收益 | -794.42 | -785.17 | - | - |
| 归属于母公司股东的其他综合收益 | -794.42 | -785.17 | - | - |
| 九、综合收益总额 | 17,505,455.66 | 9,816,794.82 | 6,277,910.07 | 27,490,186.03 |
| 归属于母公司股东的综合收益总额 | 17,686,140.58 | 9,932,098.03 | 6,334,320.18 | 27,544,279.22 |
| 归属于少数股东的综合收益总额 | -180,684.92 | -115,303.21 | -56,410.11 | -54,093.19 |
| 公告日期 | 2025-10-29 | 2025-08-26 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |